Skip to main content

Q - Evolus,

For the period ended Jun 30, 2025. Filed Aug 5, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 5, 2025

EOLS$6.81-2.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Operations and Comprehensive Loss

(in thousands, except share and per share data; Unaudited)

Three Months EndedJune 30,Six Months EndedJune 30,
2025202420252024
Revenue:
Product revenue, net$68,699$66,222$136,773$125,186
Service revenue6886871,1361,056
Total net revenues69,38766,909137,909126,242
Cost of goods sold24,06719,84145,93438,671
Gross profit45,32047,06891,97587,571
Operating expenses:
Selling, general and administrative56,67550,152113,31595,275
Research and development1,8372,3504,0494,428
Revaluation of contingent royalty obligation payable to Evolus Founders(3,914)1,605(1,763)3,183
Depreciation and amortization9326631,7561,309
Total operating expenses55,53054,770117,357104,195
Loss from operations(10,210)(7,702)(25,382)(16,624)
Other income (expense):
Interest income4791,0291,1891,546
Interest expense(7,207)(4,696)(11,622)(9,398)
Other income (expense), net(151)62(94)107
Loss before income taxes(17,089)(11,307)(35,909)(24,369)
Income tax expense(53)(43)(125)(90)
Net loss$(17,142)$(11,350)$(36,034)$(24,459)
Other comprehensive income (loss), net of tax:
Currency translation adjustment240(44)306(174)
Comprehensive loss$(16,902)$(11,394)$(35,728)$(24,633)
Net loss per share, basic and diluted$(0.27)$(0.18)$(0.56)$(0.40)
Weighted-average shares outstanding used to compute basic and diluted net loss per share64,539,29162,724,60464,120,28760,760,958
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.